SCHEMBL6645317

SCHEMBL6645317

CS(=O)(=O)NCCCOc1ccc(C(N)=O)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 5/20 0.54
ALDH1A1 P00352 2/20 0.52
HTT P42858 2/20 0.51
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
NPC1 O15118 2/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
RAB9A P51151 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
GAA P10253 1/20 0.49
HRH3 Q9Y5N1 1/20 0.47
SAE1 Q9UBE0 1/20 0.46
UBA2 Q9UBT2 1/20 0.46
USP2 O75604 1/20 0.46
ALOX15 P16050 1/20 0.46
TSHR P16473 1/20 0.46
MAPK1 P28482 1/20 0.46
HSD17B10 Q99714 1/20 0.46
PKM P14618 1/20 0.45
POLB P06746 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6800359 0.82 TSHR (0.63) ALDH1A1HTTMEN1KMT2ANPC1
SCHEMBL6645319 0.81 ALDH1A1 (0.57) ALDH1A1HTTMEN1KMT2ANPC1
SCHEMBL5724775 0.81 MAPT (0.68) ALDH1A1HTTMEN1KMT2ANPC1
SCHEMBL14410510 0.80 DRD2 (0.61) ALDH1A1HTTMEN1KMT2ANPC1
SCHEMBL13715503 0.80 PARP10 (0.62) PARP10ALDH1A1KMT2ANPC1L3MBTL1
SCHEMBL13301478 0.79 ALDH1A1 (0.62) ALDH1A1HTTMEN1KMT2ANPC1
SCHEMBL1086686 0.77 PARP10 (0.72) PARP10NPC1L3MBTL1RAB9ASMN1; SMN2
SCHEMBL6309831 0.77 PARP10 (0.62) PARP10ALDH1A1MEN1KMT2ANPC1
SCHEMBL6400068 0.77 HRH2 (0.50) ALDH1A1MEN1KMT2AL3MBTL1GAA
SCHEMBL30969281 0.77 PARP10 (0.57) PARP10ALDH1A1NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1453831-A1 1H-PYRROLO(3,2-B)PYRIDINE-3-CARBOXYLIC ACID AMIDES Neurogen Corporation (US) 2004-09-08 EP claimed
US-6673811-B1 TREATMENT OF ANXIETY, DEPRESSION, SLEEP DISORDER, ATTENTION DEFICIT DISORDER, ALZHEIMER'S DEMENTIA, OR SHORT-TERM MEMORY LOSS NEUROGEN CORPORATION 2004-01-06 US claimed
WO-2003044018-A1 1H-PYRROLO[3,2-B]PYRIDINE-3-CARBOXYLIC ACID AMIDES NEUROGEN CORPORATION (US) 2003-05-30 WO claimed
US-6673811-B1 TREATMENT OF ANXIETY, DEPRESSION, SLEEP DISORDER, ATTENTION DEFICIT DISORDER, ALZHEIMER'S DEMENTIA, OR SHORT-TERM MEMORY LOSS NEUROGEN CORPORATION 2004-01-06 US disclosed